mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |